These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37209573)

  • 1. Relationship between the Warburg effect in tumour cells and the tumour microenvironment in colorectal cancer patients: Results from a large multicentre study.
    Steeghs JPJM; Offermans K; Jenniskens JCA; Samarska I; Fazzi GE; van den Brandt PA; Grabsch HI
    Pathol Res Pract; 2023 Jul; 247():154518. PubMed ID: 37209573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients.
    Offermans K; Reitsam NG; Simons CCJM; Grosser B; Zimmermann J; Grabsch HI; Märkl B; van den Brandt PA
    Cancer Metab; 2024 Jul; 12(1):21. PubMed ID: 38992781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of proteins associated with the Warburg-effect and survival in colorectal cancer.
    Offermans K; Jenniskens JC; Simons CC; Samarska I; Fazzi GE; Smits KM; Schouten LJ; Weijenberg MP; Grabsch HI; van den Brandt PA
    J Pathol Clin Res; 2022 Mar; 8(2):169-180. PubMed ID: 34791830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer.
    Song X; Xie D; Tan F; Zhou Y; Li Y; Zhou Z; Pei Q; Pei H
    Aging (Albany NY); 2021 Aug; 13(16):20609-20628. PubMed ID: 34438367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes.
    Offermans K; Jenniskens JCA; Simons CCJM; Samarska I; Fazzi GE; Smits KM; Schouten LJ; Weijenberg MP; Grabsch HI; van den Brandt PA
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6271-6282. PubMed ID: 36723668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatory statuses of tumor stromal percentage and tumor infiltrating lymphocytes as prognostic factors in stage III colorectal cancers.
    Jin HY; Yoo SY; Lee JA; Wen X; Kim Y; Park HE; Kwak Y; Cho NY; Bae JM; Kim JH; Lee HS; Kang GH
    J Gastroenterol Hepatol; 2022 Mar; 37(3):551-557. PubMed ID: 35018665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
    Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
    Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
    Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
    Front Immunol; 2022; 13():962056. PubMed ID: 36189233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer.
    Qin M; Chen G; Hou J; Wang L; Wang Q; Wang L; Jiang D; Hu Y; Xie B; Chen J; Wei H; Xu G
    Bioengineered; 2022 Jun; 13(6):14872-14888. PubMed ID: 36633318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
    Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.
    Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA
    Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study.
    Hynes SO; Coleman HG; Kelly PJ; Irwin S; O'Neill RF; Gray RT; McGready C; Dunne PD; McQuaid S; James JA; Salto-Tellez M; Loughrey MB
    Histopathology; 2017 Jul; 71(1):12-26. PubMed ID: 28165633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between mutational subgroups, Warburg-subtypes, and survival in patients with colorectal cancer.
    Offermans K; Jenniskens JCA; Simons CCJM; Samarska I; Fazzi GE; van der Meer JRM; Smits KM; Schouten LJ; Weijenberg MP; Grabsch HI; van den Brandt PA
    Cancer Med; 2023 Jan; 12(2):1137-1156. PubMed ID: 35785488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Her2-low in colorectal cancer and its relations with the tumor microenvironment.
    Lang-Schwarz C; Vieth M; Dregelies T; Sterlacci W
    Pathol Res Pract; 2023 Apr; 244():154417. PubMed ID: 36947983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative, biopsy-based assessment of the tumour microenvironment in patients with primary operable colorectal cancer.
    Park JH; van Wyk H; McMillan DC; Edwards J; Orange C; Horgan PG; Roxburgh CS
    J Pathol Clin Res; 2020 Jan; 6(1):30-39. PubMed ID: 31486287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.
    Berntsson J; Svensson MC; Leandersson K; Nodin B; Micke P; Larsson AH; Eberhard J; Jirström K
    Int J Cancer; 2017 Oct; 141(8):1654-1666. PubMed ID: 28677162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.